Abstract
Genetic as well as environmental factors are of importance for the population variation in lipid and apolipoproteins. Several of these variables are known or believed to be of importance for susceptibility or resistance to atherogenesis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berg, K. (1984) ‘Twin studies of coronary heart disease and its risk factors’, Acta Genet. Med. Gemellol. 33, 349–361.
Berg, K. (1986) ‘DNA polymorphism at the apolipoprotein — locus is associated with lipoprotein level’, Clin. Genet. 30, 515–520.
Berg, K. (1987) ‘Genetics of coronary heart disease and its risk factors’, in G. Bock and G.M. Collins (eds.), Molecular Approaches to Human Polygenic Disease, Ciba Foundation Symposium 130, John Wiley & Sons, Chichester, pp. 14–33.
Berg, K. (1988) ‘Variability gene effect on cholesterol at the Kidd blood group locus’, Clin. Genet. 33, 102–107.
Berg, K. (1990a) ‘Molecular genetics and nutrition’, in G.H. Bourne (ed.), World Review of Nutrition and Dietetics, Karger, Basel, pp. 49–59.
Berg, K. (1990b) ‘Level genes and variability genes in the etiology of hyperlipidemia and atherosclerosis1’, in K. Berg, N. Retterstøl and S. Refsum (eds.), From Phenotype to Gene in Common Disorders, Munksgaard, Copenhagen, pp. 77–91.
Berg, K. (1992) ‘Lp(a) lipoprotein: An important genetic risk factor for atherosclerosis’, in A.J. Lusis, J. Rotter and R. Sparkes (eds.), Monogr. Hum. Genet., Karger, Basel, in press.
Berg K., Dahlén, G. and Frick, M.H. (1974) ‘Lp(a) lipoprotein and pre-βl-lipoprotein in patients with coronary heart disease’, Clin. Genet. 6, 230–235.
Berg K., Hames C., Dahlén, G., Frick, M.H. and Krishan, I. (1976) ‘Genetic variation in serum low density lipoproteins and lipid levels in man’, Proc. Natl. Acad. Sci. (USA) 73, 937–940.
Berg K., Powell, L.M., Wallis, S.C., Pease R., Knott, T.J. and Scott, J. (1986) ‘Genetic linkage between the antigenic group (Ag) variation and the apolipoprotein — gene: Assignment of the Ag locus’, Proc. Natl. Acad. Sci. USA 83, 7367–7370.
Dahlén, G. (1990) ‘Clinical significance of Lp(a) lipoprotein’, in K. Berg, N. Retterstøl and S. Refsum (eds.), From Phenotype to Gene in Common Disorders, Munksgaard, Copenhagen, pp. 163–178.
Freeman D., Lindsay G., McCusker L., Gaffney D., Packard, C. and Shepherd, J. (1992) ‘Plasma HDL-2 concentration is associated with polymorphisms of the cholesteryl ester transfer protein gene (CETP) and smoking status’, in Abstracts, European Atherosclerosis Society, 59th EAS Congress, 75.
Groover, M.E., Jernigan, J.A. and Martin, CD. (1960) ‘Variations in serum lipid concentration and clinical coronary disease’, Am. J. Med. Sci. 239, 53–59.
Humphries, S.E., Green, F.R., Henney, A.M. and Talmud, P.J. (1992) ‘DNA polymorhisms: the variability gene concept and the risk of coronary artery disease’, in A.G. Beam (ed.), Genetics of Coronary Heart Disease, Institute of Medical Genetics, University of Oslo, pp. 123–142.
Katan, M.B. and Beynen, A.C. (1987) ‘Characteristics of human hypo-and hyperresponders to dietary cholesterol’, Amer. J. Epidemiol. 125, 387–399.
Katan, M.B., Beynen, A.C., De Vries J.H.M. and Nobels, A. (1986) ‘Existence of consistent hypo-and hyperresponders to dietary cholesterol in man’, Amer — Epidemiol. 123, 221–234.
Kondo I., Berg K., Drayna, D. and Lawn, R. (1989) ‘DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels’, Clin. Genet. 35, 49–56.
Law A., Powell, L.M., Brunt H., Knott, T.J., Altman, D.G., Rajput J., Wallis, S.C., Pease, R.J., Priestley, L.M., Scott J., Miller, G.J. and Miller, N.E. (1986) ‘Common DNA polymorphism within the coding sequence of the apolipoprotein — gene associated with altered lipid levels’, Lancet i, 1301–1303.
McLean, J.W., Tomlinson J.E., Kuang, W.-J., Eaton, D.L., Chen, E.Y., Fless, G.M., Scanu, A.M. and Lawn, R.M. (1987) ‘cDNA sequence of human apolipoprotein (a) is homologous to plasminogen’, Nature 330, 132–137.
Maartmann-Moe K., Magnus P., Golden, W. and Berg, K. (1981) ‘Genetics of the low density lipoprotein receptor: III. Evidence for multiple normal alleles at the low density lipoprotein receptor locus’, Clin. Genet. 20, 113–129.
Pedersen, J. and Berg, K. (1989) ‘Interaction between low density lipoprotein receptor (LDLR) and apolipoprotein — (apoE) alleles contributes to normal variation in lipid level’, Clin. Genet. 35, 331–337.
Pedersen, J.C. and Berg, K. (1990) ‘Gene-gene interaction between the low density lipoprotein receptor and apolipoprotein — loci affects lipid levels’, Clin. Genet. 38, 287–294.
Rhoads, G.G., Dahlén, G., Berg K., Morton, N.E. and Dannenberg, A.L. (1986) ‘Lp(a) lipoprotein as — risk factor for myocardial infarction’, JAMA 256, 2540–2544.
Rosengren A., Wilhelmsen L., Eriksson E., Risberg, B. and Wedel, H. (1990) ‘Lipoprotein (a) and coronary heart disease: — prospective case-control study in — general population sample of middle aged men’, Br. Med. J. 301, 1248–1251.
Utermann G., Pruin, N. and Steinmetz, A. (1979) ‘Polymorphism of apolipoprotein E. III. Effect of single polymorphic gene locus on plasma lipid levels in man’, Clin. Genet. 15, 63–72.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Berg, K. (1993). Genetic Factors Affecting Lipoprotein Metabolism. In: Catapano, A.L., Gotto, A.M., Smith, L.C., Paoletti, R. (eds) Drugs Affecting Lipid Metabolism. Medical Science Symposia Series, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1703-6_10
Download citation
DOI: https://doi.org/10.1007/978-94-011-1703-6_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4746-3
Online ISBN: 978-94-011-1703-6
eBook Packages: Springer Book Archive